University of Crete (UOC)
Μελέτη του βιολογικού ρόλου του ERF μέσω της στοχευμένης απενεργοποίησης του γονιδίου στον ποντικό
Abstract
dc:descriptionThe ETS family of transcription factors are characterized by an evolutionarily conserved DNA- binding domain, the ETS domain, of about 85 amino acid recidues that forms a winged helix-tum-helix structural motif. The family of ETS proteins includes transcriptional activators or repressors that their transcriptional activity is regulated by RAS/MAPK signaling pathway. ETS family members control important biological processes, including cell proliferation, differentiation, apoptosis,hematopoiesis, angiogenesis and oncogenesis by recognizing and binding due to the ETS domain to consensus sequences with the characteristic motif GGAA/T in the promoters and enhancers oftheir target genes. ERF is an ETS- domain protein with strong transcriptional repressor activity thatrepresses transcription through a distinct C- terminus located repressor domain. The 2.8 kb Erf mRNA encodes for an 80 kDa phospho- protein that is ubiquitously expressed in the developing mouse embryo and adult tissues as well as in all cell lines tested. ERF is an effector of the RAS/MAPK signaling pathway that is regulated through direct ERK phosphorylation. ERF- ERK interaction results in the phosphorylation of multiple serine and threonine residues within the nucleus. This phosphorylation determines its subcellular localization and thus its function as atranscriptional repressor. After mitogenic stimulation ERF is phosphorylated by Erk and exported from the nucleus to the cytoplasm, while in the absence of mitogenic stimulation ERF is unphosphorylated in the nucleus. Phosphorylation deficient ERF mutants are primarily nuclear and can arrest cell cycle at the G0/G1 phase. These data suggest that ERF may regulate genes that are activated during G1 phase. Also it has been suggested that the ERF mediated cell cycle arrest is Rb dependent. ERF can also act as a tumor suppressor since it has been shown that can suppress ets- and rasinduced tumorigenicity as well as Ewing’s sarcoma in cellular systems. In order to study the Erf function we generated Erf-/- mice through gene targeting in ES cells. Erf loss of function results in embryonic lethality at 10.5dpc due to placenta defects. Erf is expressed in extra embryonic tissues like the yolk sac endoderm and the allantois. During placenta development, Erf is expressed in the trophoblast stem cells of the extraembryonic ectoderm and in later stages in the chorion diploid cells and the labyrinthine trophoblasts. Erf -/- placentas exhibit compact chorion layer, absence of labyrinth, expanded giant cell layer and diminished spongiotrophoblast layer. Marker analysis for different cell types of the trophoblast lineage by in situ hybridization, indicated that Erf -/- placentas lack post- mitotic chorion cells as well as the terminal differentiated labyrinthine cell type, the syncytiotrophoblasts, while they show prolonged expression of trophoblast stem cell(TSC) markers, like Errò. These data suggest that loss of Erf may block terminal differentiation ofthe chorion diploid cells, revealing a new role for ETS genes in TSC differentiation. In addition, while we can see organogenesis of allantois in Erf-/- embryos, there is a delay in its growth and its proximity to the chorion. In normal placentas we have chorioallantoic fusion at 8.5dpc, while in Erf-/- placentas we can see contact between few allantois mésothélial cells and chorion cells. Finally, Erf-/- embryos have defects in the angiogenesis in areas of the head as well as in the yolk sac. While Erf-/- yolk sacs develop the primary capillary plexus, it does not further organized to the highly branched network seen in the wt yolk sacs. Thus it is conceivable that Erf may alsoparticipate in later developmental stages during angiogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2005
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadaki, Charikleia
- Παπαδάκη, Χαρίκλεια
Subjects
dc:subject × 23- ETS μεταγραφικοί παράγοντες
- Ομόζυγα μεταλλαγμένα ποντίκια
- Εμβρυϊκή θνησιμότητα
- Πλακούντας
- Χόριο
- Λεκιθικός σάκος
- Αγγειογένεση
- ETS trancription factors
- ERF
- Homozygous mutated mice
- Embryonic lethality
- Placenta
- Chorion
- Yolk sac
- Angiogenesis
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/16170